文献速递血栓与止血

人乳头瘤病毒疫苗接种后血栓形成与血小板减少症

Thrombosis and thrombocytopenia after HPV vaccination.
PubMed 文献 · J Thromb Haemost · 2021-12-07

本文报告一例25岁女性在接种九价人乳头瘤病毒(HPV)疫苗(Gardasil 9)10天后出现血小板减少、静脉血栓、D-二聚体升高及针对血小板因子4-多阴离子复合物的血小板活化抗体水平升高。患者临床与实验室特征符合近期在腺病毒载体新冠疫苗接种后描述的疫苗诱导免疫性血栓性血小板减少症(VITT)综合征。作者结论为报告了一例HPV疫苗接种后VITT,应提高对其他疫苗后也可能发生VITT的认识。

要点

  • 25岁女性接种九价HPV疫苗10天后出现血小板减少、静脉血栓和D-二聚体升高
  • 检测到针对血小板因子4-多阴离子复合物的血小板活化抗体水平升高
  • 该病例临床与实验室特征符合腺病毒载体新冠疫苗后定义的VITT综合征

核心结论

  • 作者报告一例HPV疫苗接种后发生的VITT病例,认为应提高对其他非腺病毒载体新冠疫苗也可能发生VITT的认识。

研究设计与样本

  • 病例报告:一例25岁女性,在接种九价HPV疫苗(Gardasil 9)10天后就诊。

主要发现

  • 患者表现为血小板减少、静脉血栓、D-二聚体水平升高,以及针对血小板因子4-多阴离子复合物的血小板活化抗体水平升高。
  • 患者临床和实验室特征与近期在腺病毒载体新冠疫苗接种后定义的VITT综合征相符。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaccine-induced immune thrombotic thrombocytopenia (VITT) has so far only been reported after adenovirus vector severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. OBJECTIVE: We report findings in a 25-year-old woman who presented with thrombocytopenia, venous thrombosis, elevated D-dimer levels, and high levels of platelet-activating antibodies to platelet factor 4-polyanion complexes 10 days after Gardasil 9 vaccination for human papillomavirus (HPV). The patient exhibited clinical and laboratory features in line with the recently defined VITT syndrome, described after adenoviral vector vaccination to prevent coronavirus disease 2019. CONCLUSION: We report a case of VITT following HPV vaccination. This should raise awareness of the possibility of VITT also occurring after other vaccines, not exclusively adenoviral vector-based SARS-CoV-2 vaccines.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Johansen S, Laegreid IJ, Ernstsen SL, et al. Thrombosis and thrombocytopenia after HPV vaccination. J Thromb Haemost. 2021. PMID: 34817130. doi:10.1111/jth.15604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。